Acquisition opportunity Suneva Medical has been acquired by Tiger Aesthetics Medical, LLC, suggesting a potential cross-sell of regenerative aesthetics technologies, surgical aesthetics solutions, and integration with Tiger’s expanding adipose tissue portfolio.

Structural adipose portfolio Tiger Aesthetics is actively developing and expanding its structural adipose tissue offerings, including alloClae for breast and body contouring and dermaClae for facial and hand rejuvenation, presenting a chance to bundle complementary medical devices, implants, and consumables.

Facility expansion Tiger Aesthetics is investing tens of millions to build new facilities in Milwaukee and Philadelphia, signaling growth capacity and potential demand for additional equipment, sterile processing, training labs, and service contracts.

Market momentum Recent press indicates rapid expansion and partnerships within regenerative aesthetics, creating a favorable market backdrop for sales of innovative medical devices, regenerative products, and related analytics or marketing solutions to scale deployments.

Tech and analytics fit Suneva/Tiger operations already leverage marketing and analytics tech (HubSpot, AdRoll, Taboola, Sentry, Wistia, etc.), suggesting opportunities to introduce enhanced CRM, analytics, and digital adoption tools to optimize product launches, customer journeys, and post-sale support.